Luke Nathaniel Walker serves as Executive at Cascadian Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Luke Nathaniel Walker has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 24, 2024 involved receiving (via award) 72,481 shares valued at $0.
Luke Nathaniel Walker currently holds 72,481 shares of Cascadian Therapeutics, Inc. (CASC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Luke Nathaniel Walker has been a net neutral trader of CASC stock. They have purchased $0 and sold $0 worth of shares.
Luke Nathaniel Walker's most recent insider trade was on May 24, 2024, when they sold 72,481 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 7, 2024 | HARP | $0 | Award | 115,000 | $N/A | Discretionary |
| Nov 26, 2023 | HARP | $0 | Award | 20,000 | $N/A | Discretionary |
| Mar 9, 2018 | CASC | $0 | Tender | 10,315 | $N/A | Discretionary |
| Jan 11, 2018 | CASC | $2.5K | Payment | 637 | $3.92 | Discretionary |
| Jan 11, 2018 | CASC | $0 | Option Exercise | 1,950 | $N/A | Discretionary |